Financial Data and Key Metrics Changes - Net revenues increased by 8% year-over-year to $151.7 million, exceeding the outlook of flat to up 2% [22][24] - Adjusted EBITDA margin improved by 900 basis points to 12.4% compared to 3.4% last year [5][29] - Gross margin expanded by 280 basis points to 69.9%, driven by lower discounts and improved return rates [27][29] Business Line Data and Key Metrics Changes - Scrubwear grew by 8%, representing 84% of net revenues, supported by effective merchandising and marketing [24][25] - Non-scrubwear increased by 7%, accounting for 16% of net revenues, with strong growth in underscrubs and shoes [24][25] - Average order value rose by 6% to $114, primarily due to a higher rate of full-price sales [23] Market Data and Key Metrics Changes - U.S. sales increased by 8% to $127.3 million, marking the strongest performance in nine quarters [25] - International net revenues grew by 12%, with notable strength in acquiring new customers [25][26] - Active customer count reached nearly 2.8 million, reflecting a 4% increase year-over-year [23] Company Strategy and Development Direction - The company is focusing on expanding its international presence, planning to increase from 33 to nearly 60 markets by year-end [15][17] - Investments are being made in product innovation, including new fabric solutions like FIBREX, aimed at enhancing product offerings [8][58] - The company is committed to maintaining a strong connection with healthcare professionals, emphasizing community engagement and brand authenticity [21][14] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the ongoing momentum into Q4, expecting it to be the strongest net revenue growth quarter of the year [5][31] - The company anticipates a full-year revenue growth of approximately 7%, up from previous low single-digit expectations [31] - Management acknowledged challenges from tariffs but highlighted successful mitigation strategies and operational efficiencies [36][37] Other Important Information - Inventory increased by 23% year-over-year to $151.2 million, attributed to deeper investments in key styles and earlier timing of in-transit inventory [29][30] - The company has $52 million available for future share repurchases under its current program [30] Q&A Session Summary Question: Can you discuss the gross margin performance this quarter? - Management noted a gross margin of 69.9%, higher than historical rates, driven by improved discount rates and returns processing [39][40] Question: What drove the demand during business-as-usual days without promotions? - Management reported acceleration in business-as-usual days, with broad-based performance across U.S. and international markets [41][42] Question: How do you see AOV contributing to revenue growth in 2026? - AOV increased by 6%, with expectations for continued growth driven by product mix and customer engagement [44][45] Question: What are the growth drivers for community hubs? - The company plans to open three new community hubs in key healthcare locations, leveraging learnings from existing stores [51][52] Question: How is the international market expected to grow? - Management expressed confidence in sustaining double-digit growth in international markets, supported by a two-pronged strategy of broad and deep market penetration [61][62]